REPATH LAUNCH
15 September 2026
Global
Genspect has formally launched REPATH, its Re-psychopathologisation Campaign, calling on clinicians and policymakers to replace automatic gender affirmation with thorough differential diagnosis and genuine psychiatric care. Hosts Stella O'Malley and Mia Hughes unpack what the campaign demands and why its core distinction — between transgender ideation and gender non-conformity — matters for clinical practice. In Ireland, where the HSE has been slow to adopt evidence-based safeguards, REPATH sets out a principled alternative to an affirmation-only model that has drawn mounting criticism across the English-speaking world.
On 15 September 2026, Genspect officially launched REPATH — its Re-psychopathologisation Campaign — and hosts Stella O'Malley and Mia Hughes devoted this episode of Beyond Gender to marking the occasion. The campaign represents one of the most organised clinical and policy challenges yet mounted against the affirmation-only model that has shaped gender medicine in Ireland and internationally over the past decade. REPATH draws a distinction that has become central to the debate about gender medicine: the difference between gender non-conformity and transgender ideation. The campaign is explicit that it does not seek to pathologise people who do not conform to sex-based stereotypes. What it does argue is that when a person experiences distress about their gender, that distress deserves genuine psychiatric investigation — the kind of thorough differential diagnosis that can identify co-occurring conditions before any irreversible medical pathway is pursued. The campaign's name signals its core argument. Gender dysphoria was removed from the list of mental disorders in DSM-5 and subsequently from ICD-11, decisions that REPATH contends have had profound clinical consequences: without a psychiatric framing, clinicians operating under affirmation protocols have had little institutional basis for exploring the psychological roots of a patient's distress. REPATH calls for that basis to be restored, so that psychological and psychiatric care — rather than automatic affirmation — becomes the standard first response. From an Irish perspective, the timing is significant. The Health Service Executive continues to provide gender-related care through structures that have not undergone the kind of systematic, evidence-based review that the Cass Review prompted in the United Kingdom. Linn Dara CAMHS remains Ireland's primary point of access for young people presenting with gender distress, and Irish GPs and psychiatrists operate without nationally agreed clinical guidance equivalent to what England's NHS has begun to put in place. REPATH's call for differential diagnosis and psychological support maps directly onto the gaps that Irish clinicians, parents and researchers have been identifying for several years. O'Malley and Hughes are well placed to examine what REPATH means in practice. O'Malley is a psychotherapist with long experience of working with young people, and Hughes has spent years researching gender medicine internationally. Their conversation on launch day offers both an account of the campaign's intellectual foundations and a reflection on why a formal, internationally coordinated challenge to affirmation-only practice has become necessary. For Irish listeners — parents seeking answers, clinicians looking for a defensible clinical framework, or policymakers yet to act on accumulating international evidence — REPATH advances a straightforward argument: the standards of care expected everywhere else in medicine should apply here too. Assess first, treat the whole person, and do no harm.
